Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.

Mack SC, Pajtler KW, Chavez L, Okonechnikov K, Bertrand KC, Wang X, Erkek S, Federation A, Song A, Lee C, Wang X, McDonald L, Morrow JJ, Saiakhova A, Sin-Chan P, Wu Q, Michaelraj KA, Miller TE, Hubert CG, Ryzhova M, Garzia L, Donovan L, Dombrowski S, Factor DC, Luu B, Valentim CLL, Gimple RC, Morton A, Kim L, Prager BC, Lee JJY, Wu X, Zuccaro J, Thompson Y, Holgado BL, Reimand J, Ke SQ, Tropper A, Lai S, Vijayarajah S, Doan S, Mahadev V, Miñan AF, Gröbner SN, Lienhard M, Zapatka M, Huang Z, Aldape KD, Carcaboso AM, Houghton PJ, Keir ST, Milde T, Witt H, Li Y, Li CJ, Bian XW, Jones DTW, Scott I, Singh SK, Huang A, Dirks PB, Bouffet E, Bradner JE, Ramaswamy V, Jabado N, Rutka JT, Northcott PA, Lupien M, Lichter P, Korshunov A, Scacheri PC, Pfister SM, Kool M, Taylor MD, Rich JN.

Nature. 2018 Jan 4;553(7686):101-105. doi: 10.1038/nature25169. Epub 2017 Dec 20.

2.

Targeting glioma stem cells through combined BMI1 and EZH2 inhibition.

Jin X, Kim LJY, Wu Q, Wallace LC, Prager BC, Sanvoranart T, Gimple RC, Wang X, Mack SC, Miller TE, Huang P, Valentim CL, Zhou QG, Barnholtz-Sloan JS, Bao S, Sloan AE, Rich JN.

Nat Med. 2017 Nov;23(11):1352-1361. doi: 10.1038/nm.4415. Epub 2017 Oct 9.

3.

FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.

Cheng P, Wang J, Waghmare I, Sartini S, Coviello V, Zhang Z, Kim SH, Mohyeldin A, Pavlyukov MS, Minata M, Valentim CL, Chhipa RR, Bhat KP, Dasgupta B, La Motta C, Kango-Singh M, Nakano I.

Cancer Res. 2016 Dec 15;76(24):7219-7230. Epub 2016 Aug 28.

4.

Cancer stem cells in glioblastoma.

Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN.

Genes Dev. 2015 Jun 15;29(12):1203-17. doi: 10.1101/gad.261982.115. Review.

5.

Efficient linkage mapping using exome capture and extreme QTL in schistosome parasites.

Chevalier FD, Valentim CL, LoVerde PT, Anderson TJ.

BMC Genomics. 2014 Jul 21;15:617. doi: 10.1186/1471-2164-15-617.

6.

Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites.

Valentim CL, Cioli D, Chevalier FD, Cao X, Taylor AB, Holloway SP, Pica-Mattoccia L, Guidi A, Basso A, Tsai IJ, Berriman M, Carvalho-Queiroz C, Almeida M, Aguilar H, Frantz DE, Hart PJ, LoVerde PT, Anderson TJ.

Science. 2013 Dec 13;342(6164):1385-9. doi: 10.1126/science.1243106. Epub 2013 Nov 21.

7.

Genomic linkage map of the human blood fluke Schistosoma mansoni.

Criscione CD, Valentim CL, Hirai H, LoVerde PT, Anderson TJ.

Genome Biol. 2009;10(6):R71. doi: 10.1186/gb-2009-10-6-r71. Epub 2009 Jun 30.

8.

Efficient genotyping of Schistosoma mansoni miracidia following whole genome amplification.

Valentim CL, LoVerde PT, Anderson TJ, Criscione CD.

Mol Biochem Parasitol. 2009 Jul;166(1):81-4. doi: 10.1016/j.molbiopara.2009.02.010. Epub 2009 Mar 4.

9.

Physical localization of the retrotransposons Boudicca and Perere 03 in Schistosoma mansoni.

Valentim CL, Gomes MS, Jeremias WJ, Cunha JC, Oliveira GC, Botelho AC, Pimenta PF, Janotti-Passos LK, Guerra-Sá R, Babá EH.

J Parasitol. 2008 Aug;94(4):993-5. doi: 10.1645/GE-1167.1.

PMID:
18576699
10.

Primary culture of venom glands from the Brazilian armed spider, Phoneutria nigriventer (Araneae, Ctenidae).

Silva LM, Lages CP, Venuto T, Lima RM, Diniz MV, Valentim CL, Baba EH, Pimenta PF, Fortes-Dias CL.

Toxicon. 2008 Mar 1;51(3):428-34. Epub 2007 Nov 13.

PMID:
18068746

Supplemental Content

Loading ...
Support Center